Literature DB >> 4430143

A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia.

A Grenier, C Laberge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4430143     DOI: 10.1016/0009-8981(74)90179-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  5 in total

1.  Screening for tyrosinaemia type I.

Authors:  A C Hutchesson; S K Hall; M A Preece; A Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

2.  Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.

Authors:  T C Gibbs; J Payan; E M Brett; S Lindstedt; E Holme; P T Clayton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

3.  Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".

Authors:  C R Scriver; D E Cole; S A Houghton; H L Levy; A Grenier; C Laberge
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

4.  Visceral pathology of hereditary tyrosinemia type I.

Authors:  P Russo; S O'Regan
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

5.  Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I.

Authors:  C Laberge; A Grenier; J P Valet; J Morissette
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.